Morgan Lewis represented Takeda Pharmaceutical Company Limited in its transaction with clinical-stage rare disease therapeutics company Oak Hill Bio. Oak Hill Bio plans to advance a...
You must be a Standard 1 Year member to access this content.
McDermott Will & Emery has advised Corlieve Therapeutics, while Morgan Lewis has advised uniQure on the deal. Corlieve Therapeutics completed its sale to uniQure, with its...
You must be a Standard 1 Year member to access this content.
Morgan Lewis represented Cyclerion Therapeutics in the transaction. Cyclerion Therapeutics Inc. closed a licensing agreement with Akebia Therapeutics Inc. for the development and commercialization of praliciguat,...
You must be a Standard 1 Year member to access this content.
